Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

T. Rowe Price Associates Inc reported a 10.50% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 8, 2026

T. Rowe Price Associates Inc reported a 10.50% stake in Monte Rosa Therapeutics, Inc., 8,861,282 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).

Stake
10.50%
Shares
8,861,282
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.10.50%8,861,282

Source

View original at SEC

Related